| Orders | Qty | Bid |
|---|---|---|
| 2 | 12 | 1504 |
| 1 | 2 | 1503.7 |
| 1 | 2 | 1503.6 |
| 3 | 13 | 1503.5 |
| 4 | 20 | 1503.4 |
| Ask | Qty | Orders |
|---|---|---|
| 1504.9 | 1 | 2 |
| 1505 | 1 | 2 |
| 1505.1 | 3 | 4 |
| 1505.2 | 1 | 2 |
| 1505.3 | 2 | 2 |
Vijaya Diagnostic Centre Limited operates as India’s biggest B2C-focused integrated diagnostic chain which delivers complete radiology and pathology testing services with a focus on quality and convenience. The Company delivers pathological tests and basic and advanced radiology services and nuclear medicine services through its network of facilities with modern equipment and skilled personnel for fast and precise test results.
The company started its operations in 1981 with ultrasound and echocardiography services in Hyderabad before introducing CT and MRI and nuclear diagnostics and pathology services to create an integrated testing platform in its core markets. Vijaya Diagnostic Centre received its Indian incorporation on June 05, 2002 and maintains its headquarters in Panjagutta Hyderabad while being listed on BSE and NSE stock exchanges. The company achieved public listing status in 2021 before it acquired P.H. Diagnostics in Pune to enter Eastern and Western Indian markets .
The network operates through a hub-and-spoke system which expanded to 151 centers throughout 25 cities by the end of FY25. The company operates its business across six geographic areas which include Telangana and Andhra Pradesh and Maharashtra and Karnataka and West Bengal and the National Capital Region. Vijaya has expanded its home collection services and digital booking and payment systems and report access features in addition to its in-centre testing capabilities. The company delivers Corporate Wellness programs to more than 450 multinational corporations operating throughout India .
The Company maintained 3 subsidiaries and 1 step-down subsidiary as of March 31, 2025 which demonstrated its expanding network and back-end operational capabilities.
The company achieved four decades of growth starting from 1981 and became a public company in 2021 while entering Kolkata and Pune markets and investing in 3T MRI and 160-slice Cardiac CT technology for enhanced diagnostic capacity and clinical excellence.

As of 03 Sep 2026, the share price of Vijaya Diagnostic Cen Ltd is ₹1,496.00 on the NSE and ₹1,493.75 on the BSE. The stock opened at ₹1,478.30, touched a high of ₹1,530.00 and a low of ₹1,440.00 during today's session.
Over the last 6 months, Vijaya Diagnostic Cen Ltd has given a return of 57.28%. The stock was priced at ₹979.10 on 02 Mar 2026 and has Rise to ₹1,496.00 as of 03 Sep 2026, a change of ₹516.90 per share.
Vijaya Diagnostic Cen Ltd has delivered a return of 15.77% over the last 3 months. The stock was trading at ₹1,279.40 on 03 Jun 2026 and is currently at ₹1,496.00 as of 03 Sep 2026, reflecting a Gain of ₹216.60 per share over this period.
Vijaya Diagnostic Cen Ltd has delivered 39.04% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,573.00 on 13 Aug 2026 and a 52-week low of ₹848.00 on 30 Mar 2026. It is currently trading at ₹1,496.00 as of 03 Sep 2026.
The all-time high (ATH) for Vijaya Diagnostic Cen Ltd was ₹1,518.40, recorded on 31 Aug 2026. At the current price of ₹1,496.00, the stock is trading 1.48% below its all-time high. The all-time low recorded was ₹300.40 on 14 Jun 2022.
Vijaya Diagnostic Cen Ltd has delivered a 138.85% absolute return over the past 5 years, equivalent to a CAGR of 19.02% per annum. The stock was priced at ₹626.33 in Sep 2021 and has risen to ₹1,496.00 as of 03 Sep 2026. An investment of ₹1,00,000 in Vijaya Diagnostic Cen Ltd five years ago would be worth ₹2,38,850.00 today.
Yes,Vijaya Diagnostic Cen Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 7.00 per share between FY2022 and FY2026, with the most recent dividend of ₹2.00 per share for May 26, with an ex-dividend date of 16 Sep 2026. At the current market price of ₹1,496.00, the trailing dividend yield of Vijaya Diagnostic Cen Ltd stands at 3.00%.
For Q1 FY27, Vijaya Diagnostic Cen Ltd reported: Revenue (Net Sales): ₹2185.37 Cr - Up 5.95% year-on-year from ₹2062.67 Cr in Q4 FY26. Net Income (PAT): ₹531.47 Cr - Up 0.94% year-on-year from ₹526.52 Cr in Q4 FY26.
The intraday low for Vijaya Diagnostic Cen Ltd on the NSE today was ₹1,440.00. The stock's 52-week low stands at ₹848.00, recorded on 30 Mar 2026. Today's low is 69.81% above the 52-week low, indicating the stock is trading well above its yearly lows.
The intraday high for Vijaya Diagnostic Cen Ltd on the NSE today (03 Sep 2026) was ₹1,530.00. This compares to the 52-week high of ₹1,573.00 recorded on 13 Aug 2026. Today's high was -2.73% below the 52-week high.